Clinical Trials Logo

Hypertrophy clinical trials

View clinical trials related to Hypertrophy.

Filter by:

NCT ID: NCT05291312 Not yet recruiting - Adenoid Hypertrophy Clinical Trials

EACA VS CCA in Postoperative Evaluation of Middle Ear Pressure

Start date: May 1, 2022
Phase: N/A
Study type: Interventional

Is to evaluate the effect on Eustachian Tube (ET) and changes in middle ear pressure in early period after adenoidectomy by using Endoscopic Assisted Coblation Adenoidectomy (EACA) VS Conventional Curettage Adenoidectomy (CCA)

NCT ID: NCT05259137 Not yet recruiting - Hypertrophic Scar Clinical Trials

Intra-lesional ACE Inhibitor for Treatment of Hypertrophic Scars

Start date: August 2024
Phase: Phase 2/Phase 3
Study type: Interventional

Hypertrophic scarring is a difficult and debilitating condition where one develops excessive scarring after full thickness injury to the skin. This is very common in full thickness burn injury. Currently, there is no reliable treatment of these scars. One of the more effective treatments available is serial intralesional injection of a steroid. Angiotensin II is an active peptide in the body that results in vasoconstriction of the blood vessels when activated. Medications used today like angiotensin II receptor blocks and angiotensin converting enzyme inhibitors work to prevent the activation of angiotensin II and are mainly used to help control blood pressure. Previous studies in rat models have shown that angiotensin II receptor blockers can effectively reduce scar hypertrophy. In this study, the investigators will conduct a randomized control trial with a paired split-scar design. One arm receiving the standard therapy of serial intra-lesional injections of triamcinolone acetonide (TAC) and the second arm receiving an ACE-inhibitor. The outcome will be measured using the Patient and Observer Scar Assessment Scale (POSAS), a validated assessment tool.

NCT ID: NCT05196373 Not yet recruiting - Hypertrophic Scar Clinical Trials

Safety, Tolerability, Pharmacokinetics, Immunogenicity and Efficacy of STP705 in Adult Patients With Hypertrophic Scars

Start date: June 2023
Phase: Phase 1/Phase 2
Study type: Interventional

Adult patients with hypertrophic scars 30 Subjects in Dose Escalation 20 Subjects in Dose Expansion Intrascar injection of STP705 weekly for 4 weeks

NCT ID: NCT05025644 Not yet recruiting - Clinical trials for Hypertrophic Obstructive Cardiomyopathy

Quantitative Assessment of Hypertrophic Obstructive Cardiomyopathy With Intraoperative Three-dimensional Transesophageal Echocardiography Under Provocative Dobutamine Stress Test

Start date: March 2023
Phase: Phase 4
Study type: Interventional

The objectives of this study are to determine if the left ventricle outflow tract (LVOT) gradients may be reproduced with dobutamine (DBT) provocation test in obstructive HCM patients under general anesthesia and to analyze the change in anatomic LVOT area and pressure gradients (PG) before and after septal myectomy. If the DBT stress test can reproduce preoperative gradients in HCM patients during septal myectomy surgery, surgeons will have the opportunity to assess the quality of the surgical procedure depending on the obtained gradients with DBT stress test after surgery when gradients can't be reproduced during general anesthesia after myectomy, and decide if further myectomy is required, saving a re-operation on the patient in the future.

NCT ID: NCT05004779 Not yet recruiting - Hypertrophic Scar Clinical Trials

Regenerative Effects of Human Stem Cell Media After Laser Therapy in Hypertrophic Scar

Start date: August 10, 2021
Phase: N/A
Study type: Interventional

The purpose of this study was to determine the effect of combined treatment using nonablative laser and human stem cell media (HSCM) on the regeneration of hypertrophic scars that occurred after burns.

NCT ID: NCT05002010 Not yet recruiting - Clinical trials for Chronic Kidney Diseases

Left Ventricular Hypertrophy Among Chronic Kidney Disease Patients in Assiut University Hospital

Start date: February 2022
Phase:
Study type: Observational

Assess the prevalence and features of left ventricular hypertrophy in patients with chronic kidney disease (CKD) taking into account gender differences and stage of CKD. To detect factors those predict LVH in CKD. *to assess the right ventricle dysfunction in CKD .

NCT ID: NCT04995302 Not yet recruiting - Burn Scar Clinical Trials

Microneedling Therapy With or Without Amnion Bilayer Sheeting on Scar Tissue

Start date: September 1, 2021
Phase: N/A
Study type: Interventional

The aim of this study is to compare the outcome of microneedling therapy with or without amnion bilayer sheeting on post-burn hypertrophic scar tissue. A clinical trial will be conducted with 17 samples, from September to December 2021.

NCT ID: NCT04593706 Not yet recruiting - Keloid Clinical Trials

Comparison of the Efficacy of Different Steroids in the Treatment of Abnormal Scars (Keloids, Hypertrophic Scars)

Start date: November 1, 2020
Phase: N/A
Study type: Interventional

Comparison of the Efficacy of Different Steroids in the Treatment of Abnormal Scars (Keloids and hypertrophic Scars)

NCT ID: NCT04584073 Not yet recruiting - Clinical trials for Otitis Media With Effusion

Secretory Otitis Media in Adenoids Hypertrophy Patients

Start date: October 2020
Phase: N/A
Study type: Interventional

This study aims to compare the fate of Secretory Otitis Media in patients with adenoids hypertrophy undergoing Adenoidectomy alone or with Myringotomy or with Myringotomy and Tympanostomy Tube application

NCT ID: NCT04514718 Not yet recruiting - Quality of Life Clinical Trials

Low Energy HoLEP on IPSS

Start date: August 24, 2020
Phase: N/A
Study type: Interventional

The purpose of this study is to prove that low-energy (30W) Holmium laser prostatectomy (Holeb) is not inferior to high-energy (100W) Holmium laser prostatectomy (safety and effectiveness)